HKU Chemists Develop First-in-Class Inhibitor Targeting a Key Epigenetic Regulator
January 18, 2026
January 18, 2026
HONG KONG, Jan. 18 -- The University of Hong Kong issued the following news release:
* * *
HKU Chemists Develop First-in-Class Inhibitor Targeting a Key Epigenetic Regulator
*
A research team led by Professor Xiang David Li from the Department of Chemistry at The University of Hong Kong (HKU), in collaboration with researchers from the Shenzhen Bay Laboratory and Tsinghua University, has made a breakthrough in epigenetic drug discovery. The tea . . .
* * *
HKU Chemists Develop First-in-Class Inhibitor Targeting a Key Epigenetic Regulator
*
A research team led by Professor Xiang David Li from the Department of Chemistry at The University of Hong Kong (HKU), in collaboration with researchers from the Shenzhen Bay Laboratory and Tsinghua University, has made a breakthrough in epigenetic drug discovery. The tea . . .